Cargando…
Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782537/ https://www.ncbi.nlm.nih.gov/pubmed/36569301 http://dx.doi.org/10.3389/fphar.2022.1090504 |
| _version_ | 1784857366722772992 |
|---|---|
| author | Wu, Baoming |
| author_facet | Wu, Baoming |
| author_sort | Wu, Baoming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9782537 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97825372022-12-24 Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases Wu, Baoming Front Pharmacol Pharmacology Frontiers Media S.A. 2022-12-09 /pmc/articles/PMC9782537/ /pubmed/36569301 http://dx.doi.org/10.3389/fphar.2022.1090504 Text en Copyright © 2022 Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Wu, Baoming Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title | Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title_full | Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title_fullStr | Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title_full_unstemmed | Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title_short | Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| title_sort | editorial: new compounds, novel targets and mechanism study in inflammation-associated liver diseases |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782537/ https://www.ncbi.nlm.nih.gov/pubmed/36569301 http://dx.doi.org/10.3389/fphar.2022.1090504 |
| work_keys_str_mv | AT wubaoming editorialnewcompoundsnoveltargetsandmechanismstudyininflammationassociatedliverdiseases |